Rob joined the Board of Oyster Property Group in November 2018, and has more than 20 years of financial services and property experience in both the UK and Australia.
Rob is Cromwell’s Chief Investment Officer and is responsible for Cromwell’s investment, transactions, and merger and acquisition activities. He plays a central role in the development and capital raising of new products for both Cromwell’s ASX listed business and its European and Australian funds management operations. Rob is also integral in the operations of Cromwell’s associated entities, LDK Healthcare and Oyster Property Group, is a Director on both Boards, and Chairs the Oyster Investment Committee.
Prior to joining Cromwell in 2012, he worked for some of the world’s leading financial services firms, including NM Rothschild & Sons, PricewaterhouseCoopers, and Investec Bank. While with Investec, Rob worked closely with Cromwell’s Board and senior management on a number of different transactions over the last decade, including the landmark stapling of the Group in 2006.
Rob holds a Masters in Chemical Physics from the University of Glasgow.